We’ve passed the two month mark in our countdown to the Michigan Growth Capital Symposium this May, and we’re already excited about the line-up of discussion topics and experts in entrepreneurship and investment. As part of its legacy of shining a spotlight on the extraordinary innovation and investment opportunities in the Midwest, the symposium will feature five panel discussions, two days of continuous networking opportunities and presentations from 44 of the region’s most promising companies seeking $500,000 to $20 million in funding.
This year’s panel discussions include:
- Early Stage Investing: Anatomy of a Successful Deal – moderated by Andrew McColm, of Early Stage Partners
- Investment Trends in the Life Sciences – moderated by Paul McCreadie of Arboretum Ventures, with panelists from Simpirica Spine, Versant Ventures, and BioVentures
- Navigating Regulatory Policies in Venture Capital – moderated by Michael Staebler, of Pepper Hamilton LLP
- Best Practices in Venture Capital: Leveraging the CFO – moderated by Michael Schiavo of Venture Investors LLC
- Access to Capital: The Midwest Landscape – moderated by Richard Walawender of Miller Canfield
Did you know that over the past 10 years more than 300 companies have presented at the Symposium? Seventy-one percent of them have raised capital—totaling more than $1.7 billion in investments – and nearly 20% of the companies funded have realized successful exits.
If you’d like to find out more, or register to attend the May 10-11 event at the Ann Arbor/Ypsilanti Marriott, visit www.michigangcs.com.